The National Institute of Tuberculosis and Respiratory Diseases (NITRD) in India has adopted SS Innovations International’s SSi Mantra surgical robotic system.

NITRD’s director Dr Ravindra Kumar Dewan and consultant thoracic surgeon Dr Saraansh Bansal performed lung surgery using the robotic system.

The system uses machine learning models to improve efficiency and safety while performing procedures.

Dewan said: “SSi Mantra’s surgeon’s console provides a magnified, close-up view of the surgical area compared to the traditional visual-assisted system.

“The maneuverability of the robotic arms enabled us to better access the thoracic cavity, making it far easier to perform the surgery with ease and precision.”

With its advanced ergonomics, modular, and 3D vision open-console design, the robotic system is also used during general, urology, cardiothoracic, gynaecology, head and neck surgical procedures.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

SS Innovations CEO, chairman and founder Dr Sudhir Srivastava said: “The recent successful completion of a lung surgery using the SSi Mantra system at the prestigious NITRD in New Delhi represents an important milestone in providing gold standard care to patients from across the entire spectrum of healthcare in India.”

NITRD is said to be first Indian hospital to carry out robotic surgery using the SSi Mantra surgical robotic system which is clinically validated in more than 35 different surgical procedures in the country.

SS Innovations is also planning to seek regulatory approvals from the US Food and Drug Administration (FDA) and CE Mark in Europe.